Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
527.07
+7.11 (1.37%)
At close: Jun 26, 2026, 4:00 PM EDT
527.35
+0.28 (0.05%)
After-hours: Jun 26, 2026, 7:24 PM EDT
Medpace Holdings Employees
Medpace Holdings had 6,200 employees as of December 31, 2025. The number of employees increased by 300 or 5.08% compared to the previous year.
Employees
6,200
Change (1Y)
300
Growth (1Y)
5.08%
Revenue / Employee
$431,979
Profits / Employee
$74,258
Market Cap
15.05B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6,200 | 300 | 5.08% |
| Dec 31, 2024 | 5,900 | 0 | - |
| Dec 31, 2023 | 5,900 | 700 | 13.46% |
| Dec 31, 2022 | 5,200 | 700 | 15.56% |
| Dec 31, 2021 | 4,500 | 900 | 25.00% |
| Dec 31, 2020 | 3,600 | 100 | 2.86% |
| Dec 31, 2019 | 3,500 | 600 | 20.69% |
| Dec 31, 2018 | 2,900 | 400 | 16.00% |
| Dec 31, 2017 | 2,500 | 0 | - |
| Dec 31, 2016 | 2,500 | 300 | 13.64% |
| Dec 31, 2015 | 2,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 40,100 |
| Charles River Laboratories International | 19,700 |
| Mettler-Toledo International | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,080 |
MEDP News
- 10 days ago - Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 - Business Wire
- 5 weeks ago - MEDP Fraud Notice: Medpace Sued for Securities Fraud after 16% Stock Drop -- Investors Reminded to Contact BFA Law by June 8 Case Deadline - GlobeNewsWire
- 6 weeks ago - Medpace Lawsuit Reminder: Investors with Losses after Company Discloses Cancellation Rates are Urged to Contact BFA Law before June 8 Deadline - NASDAQ:MEDP - GlobeNewsWire
- 7 weeks ago - MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money - Business Wire
- 2 months ago - Medpace price target lowered to $400 from $460 at BMO Capital - TheFly
- 2 months ago - Medpace price target lowered to $484 from $522 at RBC Capital - TheFly
- 2 months ago - Medpace price target lowered to $477 from $565 at Baird - TheFly
- 2 months ago - Medpace price target lowered to $450 from $500 at Barclays - TheFly